Moclobemide in the prophylactic treatment of migraine - A retrospective analysis of 44 cases

被引：8

作者：

Meienberg, O ^{[1
]}

Amsler, F ^{[1
]}

机构：

[1] ROCHE PHARMA,REINACH,SWITZERLAND

来源：

EUROPEAN NEUROLOGY | 1996年 / 36卷 / 02期

关键词：

D O I：

10.1159/000117221

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：109 / 110

页数：2

共 10 条

[1]

Baumel B, 1994, Neurology, V44, pS13

[2] THE POTENTIAL EFFECTIVENESS OF MOCLOBEMIDE, THE NEW MONOAMINE-OXIDASE INHIBITOR, IN THE PROPHYLAXIS OF MIGRAINE [J].

CLAMAN, JM .

HEADACHE, 1993, 33 (06) :339-339

[3] MOCLOBEMIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN DEPRESSIVE-ILLNESS [J].

FITTON, A ;

FAULDS, D ;

GOA, KL .

DRUGS, 1992, 43 (04) :561-596

[4] MOCLOBEMIDE [J].

FREEMAN, H .

LANCET, 1993, 342 (8886-7) :1528-1532

[5] THE EPIDEMIOLOGY OF MIGRAINE [J].

LIPTON, RB ;

STEWART, WF .

EUROPEAN NEUROLOGY, 1994, 34 :6-11

[6] A REVIEW OF CURRENT DRUGS FOR MIGRAINE [J].

OLESEN, J .

JOURNAL OF NEUROLOGY, 1991, 238 :S23-S27

[7]

Raskin N H, 1993, Neurology, V43, pS39

[8]

Silberstein SD, 1990, PAIN MANAGEMENT, V3, P334

[9] THE ECONOMIC AND SOCIAL IMPACT OF MIGRAINE [J].

STEWART, WF ;

LIPTON, RB .

EUROPEAN NEUROLOGY, 1994, 34 :12-17

[10]

1988, CEPHALALGIA S7, V8, P9

← 1 →